Schedule V (US Controlled Substances Act)
GPTKB entity
Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Controlled substance schedule
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:criteria |
low potential for abuse relative to Schedule IV
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:enforcedBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:example |
gptkb:pregabalin
gptkb:lacosamide cough preparations with less than 200 mg codeine per 100 ml ezogabine |
| https://www.w3.org/2000/01/rdf-schema#label |
Schedule V (US Controlled Substances Act)
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:partOf |
gptkb:US_Controlled_Substances_Act
|
| gptkbp:regulates |
controlled substances with low potential for abuse
drugs with accepted medical use drugs with limited physical or psychological dependence risk |
| gptkbp:bfsParent |
gptkb:Schedule_IV_(US_Controlled_Substances_Act)
|
| gptkbp:bfsLayer |
7
|